Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Thyrocare Technologies Limited
THYROCAREThyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited. Address: D/37-3, TTC Industrial Area, Navi Mumbai, India, 400703
Analytics
Preço Alvo de Wall Street
66 195.67 INRRácio P/E
59.8829Rendimento de dividendos
1.86 %Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave THYROCARE
Análise de Dividendos THYROCARE
Crescimento de dividendos em 5 anos
80 %Crescimento contínuo
1 anoTaxa de pagamento em média de 5 anos
96 %Histórico de Dividendos THYROCARE
Avaliação de ações THYROCARE
Relatório THYROCARE
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |